139 related articles for article (PubMed ID: 38907544)
1. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases.
Zhang Y; Liu Y; Xu J; Liang Y; Xu Z
Eur J Dermatol; 2024 Apr; 34(2):144-149. PubMed ID: 38907544
[TBL] [Abstract][Full Text] [Related]
2. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients.
Xie Y; Wang T; Wang L
J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634
[TBL] [Abstract][Full Text] [Related]
3. Hydroa vacciniforme-like lymphoproliferative disorder in Korea.
Han B; Hur K; Ohn J; Kim TM; Jeon YK; Kim YC; Mun JH
Sci Rep; 2020 Nov; 10(1):19294. PubMed ID: 33168864
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
5. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
Chen CC; Chang KC; Medeiros LJ; Lee JY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
[TBL] [Abstract][Full Text] [Related]
6. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective study on clinicopathological characteristics of 32 cases.
Xu W; Tan J; Cai C; Lei L; Cao X; Zhou H; Xu M
Pediatr Dermatol; 2022 May; 39(3):372-375. PubMed ID: 35194837
[TBL] [Abstract][Full Text] [Related]
7. Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites.
Cohen JI; Manoli I; Dowdell K; Krogmann TA; Tamura D; Radecki P; Bu W; Turk SP; Liepshutz K; Hornung RL; Fassihi H; Sarkany RP; Bonnycastle LL; Chines PS; Swift AJ; Myers TG; Levoska MA; DiGiovanna JJ; Collins FS; Kraemer KH; Pittaluga S; Jaffe ES
Blood; 2019 Jun; 133(26):2753-2764. PubMed ID: 31064750
[TBL] [Abstract][Full Text] [Related]
8. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases.
Liu Y; Ma C; Wang G; Wang L
J Am Acad Dermatol; 2019 Aug; 81(2):534-540. PubMed ID: 30654082
[TBL] [Abstract][Full Text] [Related]
9. Oral manifestations of Hydroa vacciniforme-like lymphoproliferative disorder: a clinicopathological study of a Peruvian population.
López de Cáceres CVB; Rodrigues-Fernandes CI; Rendón Henao J; Morais TML; Soares CD; de Almeida OP; Fonseca FP; Delgado-Azañero W
J Oral Pathol Med; 2021 Jul; 50(6):530-539. PubMed ID: 34097774
[TBL] [Abstract][Full Text] [Related]
10. Comparative Study of the Clinical Pathology, Immunophenotype, Epstein-Barr Virus Infection Status, and Gene Rearrangements in Adult and Child Patients With Hydroa Vacciniforme-Like Lymphoproliferative Disorder.
Wen PF; Zhang M; Wang TT; Liu HJ; Zhang WY; Liu WP; Wang L
Am J Dermatopathol; 2019 Jan; 41(1):7-15. PubMed ID: 30085959
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
13. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M
J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815
[TBL] [Abstract][Full Text] [Related]
14. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
Quintanilla-Martinez L; Ridaura C; Nagl F; Sáez-de-Ocariz M; Durán-McKinster C; Ruiz-Maldonado R; Alderete G; Grube P; Lome-Maldonado C; Bonzheim I; Fend F
Blood; 2013 Oct; 122(18):3101-10. PubMed ID: 23982171
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.
Xu Z; Lian S
Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358
[TBL] [Abstract][Full Text] [Related]
16. Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review.
Kim YJ; Yang HJ; Won CH; Chang SE; Lee MW; Lee WJ
Dermatology; 2023; 239(5):700-711. PubMed ID: 37231869
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
18. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review.
Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z
BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199
[TBL] [Abstract][Full Text] [Related]
19. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
20. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
